Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

390 public trials 102 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma

NCT00458952

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
Locations: New York Presbyterian Hospital-Weill Cornell Medical Center New York, United States

Duke University Medical Center Durham, North Carolina, United States

Rhode Island Hospital Providence, Rhode Island, United States

View Trial Details

Completed

RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation

NCT01317615

Conditions: Carcinoma, Carcinoma, Large Cell, Lung Diseases, +12 more
Locations: Novartis Investigative Site Berlin, Germany

Novartis Investigative Site Bremen, Germany

Novartis Investigative Site Cologne, Germany

Novartis Investigative Site Essen, Germany

View Trial Details

Completed

68Ga-DOTATATE PET Scan in Neuroendocrine Cancer

NCT01396382

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +19 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Completed

Study of MK-2206 in Patients With Metastatic Neuroendocrine Tumors (NET)

NCT01169649

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine Tumor

NCT01099540

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Samsung Cancer Center Seoul, South Korea

View Trial Details

Completed

Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)

NCT00610129

Conditions: Metastatic Neuroendocrine Tumors, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations: Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States

View Trial Details

Completed

B-Receptor Signaling in Cardiomyopathy

NCT01135849

Conditions: Adenocarcinoma, Adenoma, Amyloidosis, +140 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)

NCT02539433

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: North Shore University Hospital Manhasset, New York, United States

View Trial Details

Completed

DOTA-TOC in Metastasized Neuroendocrine Tumors

NCT00978211

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: University Hospital Basel, Canton of Basel-City, Switzerland

View Trial Details

Completed

A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

NCT00753415

Conditions: Adenocarcinoma, Bladder Carcinoma, Breast Cancer, +56 more
Locations: Not specified

View Trial Details